ANVATABART PACTIL
UNII 5YR4B56UBP

Substance Identification & Data

This profile provides standardized clinical and technical data for Anvatabart Pactil, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5YR4B56UBP.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2636710-06-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

5YR4B56UBP

CAS Registry Number

2636710-06-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ANVATABART PACTIL

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C190323

National Cancer Institute reference terminology for clinical and research data.

INN ID

12271

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KL-240

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Anvatabart Pactil. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ANVATABART PACTIL

Common Names & Synonyms

ANVATABART PACTIL [INN]

ANVATABART PACTIL [USAN]

ARX-788 MAB

GAMMA1 HEAVY CHAIN HUMANIZED (1-449)(VH HUMANIZED (HOMO SAPIENS IGHV3-66*01 (81.6%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT (8.8.13) (26-33.51-58.97-109)) (1-120) -HOMO SAPIENS IGHG1*01, G1M17,1 (CH1 A1.4>F (PAF) (121), K120 (217) (121-218), HINGE 1-15 (219-233), CH2 (234-343), CH3 D12 (359), L14 (361) (344-448), CHS K2>DEL (449)) (121-449)), (223-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-39*01 (86.3%) -IGKJ1*01 (100%), CDR-IMGT (6.3.9) (27-32.50-52.89-97)) (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214')); DIMER (229-229:232-232)-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA; SUBSTITUTED WITH TWO ACETYLGROUPS AT C-4 OF PHE121 AND PHE121

IMMUNOGLOBULIN G1 (121-(4-ACETYLPHENYLALANINE),DE-450-LYSINE), ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR HER2) (HUMAN-MUS MUSCULUS MONOCLONAL AMAB788 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL AMAB788 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS ERBB2 (EPIDERMAL GROWTH FACTOR RECEPTOR 2, RECEPTOR TYROSINE-PROTEIN KINASE ERBB-2, EGFR2, HER2, HER-2, P185C-ERBB2, NEU, CD340)), HUMANIZED MONOCLONAL ANTIBODY, CONJUGATED AT TWO ENGINEERED PHENYLALANINE SITES WITH P-ACETYL GROUPS

Technical Codes

ARX788 MAB

External Clinical & Regulatory Resources

Previous UNII5YR2N37E6D

Next UNII5YR9K3ZG9E